<DOC>
	<DOCNO>NCT00231660</DOCNO>
	<brief_summary>The purpose study compare efficacy ( term weight hemoglobin type A1c [ HbA1c ] ) safety topiramate ( 96 milligram [ mg ] 192 mg daily ) placebo treatment obesity Type 2 diabetic patient receive metformin .</brief_summary>
	<brief_title>A Study Efficacy Safety Topiramate Treatment fo Obese , Type 2 Diabetic Patients Treated With Metformin</brief_title>
	<detailed_description>Topiramate approve treatment obesity . This double-blind , placebo-controlled study design ass efficacy safety topiramate Type 2 diabetic patient obesity well-controlled metformin alone . Patients randomize receive either topiramate ( target dose 96 192 mg per day ) placebo one year . Assessments efficacy include weight reduction , level HbA1c ( show average blood sugar level month ) , Body Mass Index ( BMI ) , Health Related Quality Life ( HRQOL ) measure . Safety evaluation ( incidence adverse event , vital sign , hypoglycemic event , electrocardiogram [ ECGs ] , clinical laboratory value ) monitor throughout study . The study hypothesis topiramate , combine metformin non-pharmacologic therapy , effectively achieve significant weight reduction well tolerate . During first 8 week , oral dos match placebo topiramate increase gradually target dose ( 96 milligram [ mg ] 192mg daily ) ; dose maintain 1 year , gradually reduce stop</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Diagnosis Type 2 diabetes receive metformin monotherapy least previous 4 month stable daily dose least 2 month prior enrollment Metformin total daily dose exceed 2.1 grams/day Body Mass Index &gt; = 27 &lt; 50 HbA1c &lt; 11 % Fasting plasma glucose &gt; = 126 &lt; 240 Stable weight Female patient must postmenopausal least 1 year , surgically incapable childbearing , practice acceptable method contraception ( require negative pregnancy test ) Known contraindication , hypersensitivity topiramate Use antidiabetic medication within last 4 month Excessive weight loss Diagnosis type 1 diabetes History severe recurrent hypoglycemic episode Severe pulmonary disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Obesity</keyword>
	<keyword>Metformin</keyword>
	<keyword>Hemoglobin A1c</keyword>
	<keyword>Adult-Onset Diabetes Mellitus ( AODM )</keyword>
</DOC>